People · Operator
Named in public records as an officer, director or promoter · active 2023–2023 · Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Enzo Biochem Inc | — | Other Health Care | Series A | $7.0M | $50.3M | 2023 |
Matthew Kupferberg at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Matthew Kupferberg on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Elazar L. Rabbani, Ph.D. | 1 | 1 |
| Bradley L. Radoff | 1 | 1 |
| Patricia Eckert | 1 | 1 |
| Ian L. Walters, M.D. | 1 | 1 |
| Hamid Erfanian | 1 | 1 |
| Dieter Schapfel, M.D. | 1 | 1 |
| Kara Cannon | 1 | 1 |
| Mary L. Tagliaferri, M.D. | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.